Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)

NCT01215851 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: PA-824
DRUG: Pyrazinamide
DRUG: TMC207
DRUG: Rifafour
DRUG: Moxifloxacin

Sponsor

Global Alliance for TB Drug Development